España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
ProPhase Labs
PRPH
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.21
0.08
2.56%
Last update: 11:46 AM
15 minutes delayed
Get Report
Comment
ProPhase Labs (PRPH) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ProPhase Labs (NASDAQ:PRPH) Stock
ProPhase Labs Stock (NASDAQ: PRPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
ProPhase Labs Announces Update On Pharmaloz M...
Benzinga Newsdesk
Thursday, May 09, 2024
ProPhase Labs Q1 2024 GAAP EPS $(0.07) Beats ...
Benzinga Newsdesk
Tuesday, April 16, 2024
ProPhase Labs Unveils Project ZenQ-AI; Levera...
Benzinga Newsdesk
Wednesday, April 10, 2024
ProPhase Labs Seeks To Transform Esophageal C...
Benzinga Newsdesk
Friday, March 15, 2024
ProPhase Labs Q4 EPS $(0.51) Misses $(0.26) E...
Benzinga Newsdesk
Earnings Scheduled For March 15, 2024
Benzinga Insights
Thursday, March 14, 2024
ProPhase Labs's Earnings: A Preview
Benzinga Insights
Wednesday, February 21, 2024
HC Wainwright & Co. Reiterates Buy on ProPhas...
Benzinga Newsdesk
Tuesday, February 20, 2024
ProPhase Labs Announces Progress In BE-Smart Esophageal Cancer Test Development USPTO Grants Additional Broad Patents For BE-SMART
Happy Mohamed
Wednesday, February 14, 2024
ProPhase Labs Announces Preliminary Results F...
Benzinga Newsdesk
Tuesday, January 23, 2024
ProPhase Labs Announces Progress At Pharmaloz...
Benzinga Newsdesk
Thursday, January 04, 2024
Prophase Poised To Ramp Up Growth At Pharmalo...
Benzinga Newsdesk
Friday, November 10, 2023
HC Wainwright & Co. Maintains Buy on ProPhase...
Benzinga Newsdesk
Thursday, November 09, 2023
ProPhase Labs Q3 EPS $(0.30) Misses $(0.20) E...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Wednesday, November 08, 2023
ProPhase Labs Earnings Preview
Benzinga Insights
Tuesday, October 17, 2023
Prophase Labs Inc Says Pharmaloz Plan Is To B...
Benzinga Newsdesk
Thursday, October 12, 2023
DSS Inc. Issues Letter To Shareholders Providing An Update On Progress So Far This Year And Expectations Going Into The End Of The Year
Happy Mohamed
Tuesday, August 29, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 28, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Monday, August 14, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on ProPhas...
Benzinga Newsdesk
Friday, August 11, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, August 10, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
ProPhase Labs Q2 EPS $(0.20) Misses $(0.14) E...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Thursday, August 03, 2023
ProPhase Labs Teams Up With Certis Oncology T...
Benzinga Newsdesk
Wednesday, July 26, 2023
DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff
David Willey
-
Sponsored
Thursday, June 29, 2023
Navidea Biopharmaceuticals Rejects ProPhase L...
Benzinga Newsdesk
Monday, June 26, 2023
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
David Willey
-
Sponsored
Friday, June 02, 2023
HC Wainwright & Co. Reiterates Buy on ProPhas...
Benzinga Newsdesk
Thursday, June 01, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
ProPhase Labs' Cancer Therapeutic, Linebacker-1, Pre-Clinical Studies With Dana Farber/Harvard Cancer Institute Demonstrate Impressive Utility And Move Into Next Phase Of Testing
Happy Mohamed
Friday, May 12, 2023
Analyst Expectations for ProPhase Labs's Future
Benzinga Insights
HC Wainwright & Co. Maintains Buy on ProPhase...
Benzinga Newsdesk
Thursday, May 11, 2023
Earnings Scheduled For May 11, 2023
Benzinga Insights
Recap: ProPhase Labs Q1 Earnings
Benzinga Insights
ProPhase Labs Q1 EPS $0.03 Beats $(0.09) Esti...
Benzinga Newsdesk
Wednesday, May 03, 2023
ProPhase Labs Says 'pre-clinical data generat...
Benzinga Newsdesk
Monday, April 10, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, April 03, 2023
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
Tuesday, March 28, 2023
ProPhase Labs FY EPS $1.02 Misses $1.15 Estim...
Benzinga Newsdesk
Earnings Scheduled For March 28, 2023
Benzinga Insights
Monday, March 27, 2023
ProPhase Labs Earnings Preview
Benzinga Insights
Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
Ernest Dela Aglanu
-
Sponsored
Wednesday, March 15, 2023
ProPhase Labs Announces New $6M Stock Repurch...
Bill Haddad
Wednesday, March 08, 2023
HC Wainwright & Co. Reiterates Buy on ProPhas...
Benzinga Newsdesk
Wednesday, March 01, 2023
Prophase Labs Collaboration With mProbe And D...
Benzinga Newsdesk
Thursday, February 23, 2023
HC Wainwright & Co. Reiterates Buy on ProPhas...
Benzinga Newsdesk
Wednesday, February 22, 2023
ProPhase Labs Announces Plans To Initiate Clinical Trial Of Equivir, Goal To Launch Commercially In Q4 2023
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
